You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
As the only open-irrigated RF catheter with industrial diamonds to optimize power based on tissue surface temperature, the DiamondTemp™ ablation system (DTA) with RealTemp™ is safe and effective, and has demonstrated procedural efficiencies compared to contact force-sensing RF.1Product Details
The Arctic Front Advance™ and Arctic Front Advance Pro™ cardiac cryoablation catheters are approved in the United States to treat drug-refractory, recurrent, symptomatic, paroxysmal, and persistent atrial fibrillation (episode duration less than six months). The Arctic Front Advance and Arctic Front Advance Pro cardiac cryoablation catheters are also approved to treat recurrent, symptomatic, paroxysmal atrial fibrillation as an alternative to anti-arrhythmic drug therapy as an initial rhythm control strategy.
The catheters have a proven safety and efficacy profile in treating AF.2Product Details
The Arctic Front Cryoballoon Catheter family are the leading cryoballoon catheters approved in Europe to treat atrial fibrillation (AF). They have a low complication risk and a proven efficacy in treating AF.1
The Achieve™ and Achieve Advance™ mapping catheters are intra-cardiac electrophysiology diagnostic catheters designed for use with the Arctic Front family of cardiac cryoablation catheters, the FlexCath™ Advance steerable sheath, and the CryoConsole™.Product Details
The CryoConsole houses the components and software needed to perform cryoablation procedures with the Arctic Front family of cardiac cryoablation catheters or the Freezor family of cardiac cryoablation catheters. It controls the delivery, recovery, and disposal of cryoablation refrigerant safely and efficiently.Product Details
The FlexCath advance steerable sheath is part of the Arctic Front cardiac cryoablation catheter system and is the only sheath that has been tested for use with the Arctic Front family of cardiac cryoablation catheters. It can also be used with the Freezor MAX cardiac cryoablation catheter.Product Details
Kautzner J, Albenque JP, Natale A, et al. A Novel Temperature-Controlled Radiofrequency Catheter Ablation System Used to Treat Patients With Paroxysmal Atrial Fibrillation. JACC Clin Electrophysiol. March 2021;7(3):352-363.
Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. April 23, 2013;61(16):1713-1723.
The Freezor™ family of cardiac cryoablation catheters are flexible, single-use, minimally invasive devices designed to ablate cardiac tissue. Used in conjunction with the CryoConsole, they are the only focal catheters that utilize the Cryo energy source, with ablation indications ranging from atrioventricular nodal reentry tachycardia (AVNRT) to atrial arrhythmias.
The CryoConsole houses the components and software needed to perform Cryoablation procedures with the Arctic Front Cardiac Cryoablation Catheter Family or the Freezor family of cardiac cryoablation catheters. It controls the delivery, recovery, and disposal of cryoablation refrigerant safely and efficiently.
The FlexCath Advance™ Steerable Sheath is part of the Arctic Front Cardiac Cryoablation Catheter Family and Arctic Front Advance Pro™ Cardiac Cryoablation Catheter System and is the only sheath that has been tested for use with the Arctic Front Advance Pro™ Cardiac Cryoablation Catheter. It can also be used with the Freezor™ family of Cardiac Cryoablation Catheters.
The Pulmonary Vein Ablation Catheter GOLD (PVAC™ GOLD) is designed to be used for the creation of endocardial lesions (focal and linear) during cardiac ablation procedures for the treatment of symptomatic atrial fibrillation (AF). The PVAC Gold is also intended to be used for cardiac electrophysiological (EP) mapping of pulmonary vein potentials, delivery of diagnostic pacing stimuli, and verifying electrical isolation of the pulmonary veins post-treatment.
Kuck KH,et al. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. NEJM April 2016. DOI: 10.1056/NEJM oa1602014